Annual ROE
-31.36%
+11.49%+26.81%
December 31, 2023
Summary
- As of February 12, 2025, CGON annual return on equity is -31.36%, with the most recent change of +11.49% (+26.81%) on December 31, 2023.
- During the last 3 years, CGON annual ROE has risen by +0.54% (+1.69%).
- CGON annual ROE is now at all-time high.
Performance
CGON ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-17.82%
+1.85%+9.41%
September 30, 2024
Summary
- As of February 12, 2025, CGON quarterly return on equity is -17.82%, with the most recent change of +1.85% (+9.41%) on September 30, 2024.
- Over the past year, CGON quarterly ROE has increased by +3.27% (+15.50%).
- CGON quarterly ROE is now -165.97% below its all-time high of -6.70%, reached on December 1, 2022.
Performance
CGON Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CGON ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.8% | +15.5% |
| 3 y3 years | +1.7% | +22.2% |
| 5 y5 years | +1.7% | +22.2% |
CGON ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.8% | -166.0% | +37.7% |
| 5 y | 5-year | at high | +26.8% | -166.0% | +37.7% |
| alltime | all time | at high | +26.8% | -166.0% | +37.7% |
CG Oncology ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -17.82%(-9.4%) |
| Jun 2024 | - | -19.67%(-6.7%) |
| Mar 2024 | - | -21.09%(-26.3%) |
| Dec 2023 | -31.36% | -28.60%(+15.0%) |
| Sep 2023 | - | -24.88%(+8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -22.91%(+68.1%) |
| Mar 2023 | - | -13.63%(+103.4%) |
| Dec 2022 | -42.85%(+34.3%) | - |
| Dec 2022 | - | -6.70% |
| Dec 2021 | -31.90% | - |
FAQ
- What is CG Oncology annual return on equity?
- What is the all time high annual ROE for CG Oncology?
- What is CG Oncology annual ROE year-on-year change?
- What is CG Oncology quarterly return on equity?
- What is the all time high quarterly ROE for CG Oncology?
- What is CG Oncology quarterly ROE year-on-year change?
What is CG Oncology annual return on equity?
The current annual ROE of CGON is -31.36%
What is the all time high annual ROE for CG Oncology?
CG Oncology all-time high annual return on equity is -31.36%
What is CG Oncology annual ROE year-on-year change?
Over the past year, CGON annual return on equity has changed by +11.49% (+26.81%)
What is CG Oncology quarterly return on equity?
The current quarterly ROE of CGON is -17.82%
What is the all time high quarterly ROE for CG Oncology?
CG Oncology all-time high quarterly return on equity is -6.70%
What is CG Oncology quarterly ROE year-on-year change?
Over the past year, CGON quarterly return on equity has changed by +3.27% (+15.50%)